Abstract | OBJECTIVES: METHODS: Using quantitative RT-PCR the abundance of mature miRNAs in plasma was determined in 85 female patients with ACA-positive lcSSc. Twenty-two of the patients had SSc- APAH. Sixty-three SSc controls without PAH were matched for disease duration. Forty-six selected miRNA plasma levels were correlated with clinical data. Longitudinal samples were analysed from 14 SSc- APAH and 27 SSc patients. RESULTS: The disease duration was 12 years for the SSc- APAH patients and 12.7 years for the SSc controls. Plasma expression levels of 11 miRNAs were lower in patients with SSc- APAH. Four miRNAs displayed higher plasma levels in SSc- APAH patients compared with SSc controls. There was significant difference between groups for miR-20a-5p and miR-203a-3p when correcting for multiple comparisons (P = 0.002 for both). Receiver operating characteristics curve showed AUC = 0.69-0.83 for miR-21-5p and miR-20a-5p or their combination. miR-20a-5p and miR-203a-3p correlated inversely with NT-pro-Brain Natriuretic Protein levels (r = -0.42 and -0.47). Mixed effect model analysis could not identify any miRNAs as predictor of PAH development. However, miR-20a-5p plasma levels were lower in the longitudinal samples of SSc- APAH patients than in the SSc controls. CONCLUSIONS: Our study links expression levels of the circulating plasma miRNAs, especially miR-20a-5p and miR-203a-3p, to the occurrence of SSc- APAH in female patients with ACA-positive lcSSc.
|
Authors | Dirk M Wuttge, Anting L Carlsen, Gabriel Teku, Marie Wildt, Göran Rådegran, Mauno Vihinen, Niels H H Heegaard, Roger Hesselstrand |
Journal | Rheumatology (Oxford, England)
(Rheumatology (Oxford))
Vol. 61
Issue 1
Pg. 309-318
(12 24 2021)
ISSN: 1462-0332 [Electronic] England |
PMID | 33784391
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Rheumatology. |
Chemical References |
|
Topics |
- Aged
- Circulating MicroRNA
(blood)
- Female
- Humans
- Middle Aged
- Pulmonary Arterial Hypertension
(metabolism)
- Scleroderma, Systemic
(metabolism)
|